← Back to patent-cliff list
Fingolimod lauryl sulfate
Tier C — Watch / tradeFingolimod lauryl sulfate
Handa Neuroscience LLC
Originator
2021
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：S1PR1, S1PR3, S1PR4, S1PR5
Brand：Tascenso ODT
Indications (approved)：Relapsing-remitting multiple sclerosis
Regional status
US
Approved
2021-12-23
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Fingolimod lauryl sulfate?
Approved indications include: Relapsing-remitting multiple sclerosis.
When does the Fingolimod lauryl sulfate patent expire?
No public expiry year is available for Fingolimod lauryl sulfate yet; this page updates once verified.
How do I get a quote for Fingolimod lauryl sulfate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27